跳至主要内容
临床试验/JPRN-UMIN000006944
JPRN-UMIN000006944已完成未知

Randomized trial of doripenem or meropenem in the treatment of febrile neutropenia - Randomized trial of doripenem or meropenem in F

Tokyo Women's Medical University0 个研究点目标入组 100 人开始时间: 2012年1月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • allergic to carbapenem LC pregnant woman

研究者

发起方
Tokyo Women's Medical University

相似试验

终止
4 期
Randomized Control Trial of Meropenem versus Piperacillin-Tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia Coli and Klebsiella species.
ACTRN12615000403538Australasian Society of Infectious Diseases Clinical Research Network454
终止
3 期
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsAbscess, Intra-AbdominalAbdomen, AcuteAbdominal PainRuptureInfectionIntestinal PerforationIleusAppendicitisPeritonitisAbdominal Abscess
NCT01110382Janssen Research & Development, LLC41
招募中
4 期
Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections.Participants who have had a bloodstream infection with a specific gram negative bacteria, as defined by at least one positive blood culture, where the isolate is confirmed to be a likely AmpC-producer by resistance to Ampicillin, Amoxicillin/clavulanate and 1st generation cephalosporins (e.g. cephazolin). The isolate should also remain susceptible to piperacillin/tazobactam and meropenem.Infection - Studies of infection and infectious agents
ACTRN12614001211651The University of Queensland Centre for Clinical Research100
招募中
Unknown
Randomised Controlled Trial of Meropenem versus Cefmetazole for definitive treatment of bloodstream infections due to ESBL- producing Escherichia coli
JPRN-UMIN000049016ational Center for Global Health and Medicine, Disease Control and Prevention Center169
已完成
不适用
Efficacy and safety of Doripenem (DRPM) versus Meropenem (MEPM) in patients with febrile neutropenia (FN); Multicenter open-label randomized controlled trialfebrile neutropenia
JPRN-UMIN000006124Iwate Medical University120